Imax (IMAX) will likely keep getting market share as moviegoers around the world seem to "increasingly prefer" the company's screens, Wedbush said in a research note on Thursday.
The investment firm reiterated Imax's outperform rating and $32 price target, and also kept the company on its Best Ideas List.
Wedbush highlighted that the company has "significantly more filmed-for-Imax titles" this year and added its first exclusive for next year, which "should drive incremental market share gains for at least the next two years."
Also, Imax is diversifying its content to improve revenue and is increasing its global footprint with local-language additions, the note said.
"The 2025-2026 global film slates underscore Imax's growing prominence in Hollywood and worldwide as an essential partner for major theatrical releases across genres, languages, and geographies," the investment firm said.
Box office revenue on Imax's global screens rose 8% year on year in Q1 boosted by a record Chinese New Year, the note said.
Imax is slated to reported Q1 results on Wednesday.
Price: 22.31, Change: +0.54, Percent Change: +2.46
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.